TY - JOUR
T1 - Investigation of the multi-step dehydration reaction of theophylline monohydrate using 2-dimensional powder X-ray diffractometry
AU - Nunes, Cletus
AU - Mahendrasingam, Arumugam
AU - Suryanarayanan, Raj
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2006/10
Y1 - 2006/10
N2 - Purpose. (i) To study the dehydration kinetics of theophylline monohydrate using 2-dimensional (2D) powder X-ray diffractometry (XRD), and (ii) to investigate the effect of polyvinylpyrrolidone (PVP) on the dehydration pathway and kinetics. Methods. Theophylline monohydrate (C7H 8N4O2•H2O; M) was recrystallized from aqueous PVP solutions of different concentrations. Dehydration kinetics was studied isothermally, at several temperatures, from 35 to 130°C. The experimental set-up comprised of a high intensity X-ray source (synchrotron radiation or 8 kW rotating anode), a heating chamber, and a 2D area detector. Diffraction patterns were collected continuously, with a time resolution ranging from 40 ms to 30 s, over the angular range of 3 to 27°2θ. Results. Dehydration of M resulted in either the stable (C 7H8N4O2; A), or the metastable anhydrate (A*), with the latter having a tendency to transform to A. The XRD technique allowed simultaneous quantification of M, A*and A during the dehydration reaction. The rate constants for individual reaction steps (M→A*; M→A and A*→A) were determined by fitting the data to solid-state reaction models. In presence of PVP, there was a decrease in the magnitude of the rate constant associated with the M→A transition, resulting in an increased build-up of A*in the product. The inhibitory effect of PVP on M→A transition was more pronounced at lower dehydration temperatures, and was proportional to the concentration of PVP. Conclusions. Two dimensional powder X-ray diffractometry, using a high intensity source, is a powerful technique to study kinetics of rapid solid-state reactions. The inhibitory effect of excipients can have profound effect on phases formed during pharmaceutical processing.
AB - Purpose. (i) To study the dehydration kinetics of theophylline monohydrate using 2-dimensional (2D) powder X-ray diffractometry (XRD), and (ii) to investigate the effect of polyvinylpyrrolidone (PVP) on the dehydration pathway and kinetics. Methods. Theophylline monohydrate (C7H 8N4O2•H2O; M) was recrystallized from aqueous PVP solutions of different concentrations. Dehydration kinetics was studied isothermally, at several temperatures, from 35 to 130°C. The experimental set-up comprised of a high intensity X-ray source (synchrotron radiation or 8 kW rotating anode), a heating chamber, and a 2D area detector. Diffraction patterns were collected continuously, with a time resolution ranging from 40 ms to 30 s, over the angular range of 3 to 27°2θ. Results. Dehydration of M resulted in either the stable (C 7H8N4O2; A), or the metastable anhydrate (A*), with the latter having a tendency to transform to A. The XRD technique allowed simultaneous quantification of M, A*and A during the dehydration reaction. The rate constants for individual reaction steps (M→A*; M→A and A*→A) were determined by fitting the data to solid-state reaction models. In presence of PVP, there was a decrease in the magnitude of the rate constant associated with the M→A transition, resulting in an increased build-up of A*in the product. The inhibitory effect of PVP on M→A transition was more pronounced at lower dehydration temperatures, and was proportional to the concentration of PVP. Conclusions. Two dimensional powder X-ray diffractometry, using a high intensity source, is a powerful technique to study kinetics of rapid solid-state reactions. The inhibitory effect of excipients can have profound effect on phases formed during pharmaceutical processing.
KW - Anhydrate
KW - Dehydration
KW - Metastable
KW - Polymorph
KW - Synchrotron
KW - Theophylline monohydrate
KW - Two-dimensional
KW - X-ray diffraction
UR - http://www.scopus.com/inward/record.url?scp=33749446863&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33749446863&partnerID=8YFLogxK
U2 - 10.1007/s11095-006-9022-5
DO - 10.1007/s11095-006-9022-5
M3 - Article
C2 - 16947081
AN - SCOPUS:33749446863
SN - 0724-8741
VL - 23
SP - 2393
EP - 2404
JO - Pharmaceutical research
JF - Pharmaceutical research
IS - 10
ER -